Errata

2
ERRATA The legends for fìgures 1 and 2 in the article “Ccrcbral hypcrpcrfusion syndromc following aortocarotid bypass surgcp“ (Waikar HD. et al: J Cardiothomc Vast Anesth 7:46 1-465. 1943) should rcad Fig. 1. Arch aortogram showing total occlusion of the left common carotid artery, both subclavian arteries, and stenosis of the innominate artery, and the proximal right common carotid artery. (Reprinted with permission of Springer-Verlag.) Fig. 2. Postoperative CT scan shows bihemispheric hematoma more on the right side. (Reprinted with permission of Springer-Verlag.) Thc correct vcrsions of tables 1 and 7 and thc tigure legend for Fig 4 in thc article “Diltiazcm and regional left ventricular function during gradcd coronary constriction and propofol anesthcsia in thc dog” (Goldberg AH. ct al. J Cardiothorac VUSC Anrsth 7:705-710. 1993) are rcprinted bclow. On page 705. column 2. lint 2. thc dosage of morphinc sulfatc should read 0.1 mgikg, IM. Fig. 4. Regression analysis of postsystolic shortening versus LAD coronary blood How (means t SE). The slope of each regression line is significantly different from zero (prediltiazem P = 0.018, postdiltiazem P = 0.012), while also being coincident with the other (P = 0.348). Abbreviations: TS, total muscle shortening; LAD, left anterior descending coronary artery. Table 1. Global Hemodynamics Dwing Graded Irchsmia and Diltiazrm (means i SD) Parameter COIltrOl Ischemia 2 TOlal Occlusiorl Heart rate (beats/min) Systolic arterial pressure (mmlig) Diastolic arterial pressure ImmHg) LV dP/d& (mmHg/sec) Systemic vascular resistance (mmHg/L/minl Stroke volume (mL1 Cardiac output ImLlmin) LAD coronary blood flow (mL/min/lOO g) LAD coronary blood flow I% of Control) LV end-diastolic pressure (mmHg) Coronary perfusion pressure ImmHgl 103.8 i 24.6$ 120.4 L 17.8t9 128.6 + 14.3$ 97.9 + 12.6tl 98.6 + 8.1Z 69.5 + 16.2t§ 1696.3 i 457: 1206.3 - 228tS 71 .a -L_ 35.9* 68.4 + 22.25 17.7 I 6.9$ 10.5 + 3.4t4. 2480 + 184$ 1777 + 123tl 120.2 + 42.4$ 90.7 + 38.4TS 100 + o* 100 I os 8.3 z 2.4* 4.8 1 Z.OT§ 90.4 i 7.56$ 64.8 i 16.2t§ 107.8 c 28.3 122.3 L 18.Jt 121.5 t 11.4 92.63 2 10.8t 95.2 + 9.9 63.1 z 14.5t 1618.8 r 396 1205.0 z 319t 76.1 c 34.8 67.8 ? 18.8 15.3 2 6.4 9.6 ? 3.3t 2330 z 165 1808 ? 113t 86.2 z 30.1’ 65.6 z 21.2’ 76.6 ? 32.4’ 76.5 5 14.1* 6.3 1 1.8 4.4 ? 1.6 89.0 = 10.3 58.8 2 14.5t ?? P < 0.05 v Control. - tP < 0.05 prediltiazem Y postdiltiazem SPrediltiazem. SPostdiltiazem. 115.9 + 22.9‘ 124.0 % 18.9 116.0 i 9.7’ 93.63 + 11.2t 89.5 z 10.0 66.1 I 15.6t 1432.5 + 279’ 1180.0 + 209t 78.8 i 47.5 73.9 t 24.4 13.5 i 6.1 9.1 z3,3*t 2189 + 157 1807 f 109t 68.3 t 23.0‘ 56.6 L 22.1’ 61.0 ? 24.1’ 65.6 z 17.8’ 5.8 t 2.0 4.6 I 1.7 83.8 r 10.1 61.6 i 15.4t 117.6 + 22.6’ 124.8 z 16.9 114.8 t 7.7’ 89.38 2 13.2t 89.9 + ll.3 62.0 z 13.Jt 1413.8 i 295’ 1086.3 i 230t 74.6 + 28.6 74.1 + 22.9 12.7 - 4.1 8.5 2 3.2.t 2073 + 148’ 1788 + 104t 50.0 i la.?* 41.8 + 18.8. 47.6 5 27.3* 47.4 L 11.5’ 8.5 I 4.4 5.3 I 1.4 81.4 L 12.2 56.7 I 13.2t 125.1 2 22.7’ 128.4 i 16.2’ 105.1 c 12.2’ 86.0 2 ll.Ot 79.6 : 13.7’ 60.6 z 12.8t 1291 z 278’ 1025 L 205t 70.7 z 27.4 75.1 i 20.8 ll.2 L 3.6’ 7.8 L 2.J’t 1897 L 137’ 1533 r gat 0 2 0’ 0 2 0’ 0 c 0’ 0 2 0’ 9.6 T 4.0 9.0 2 3.2’ 70.0 2 13.6’ 51.6 z 12.4.t 258 Journal of Cardiothoraoc and Vascular Anesthesra, Vol 8, NO 2 (April). 1994: pp 258-259

Transcript of Errata

ERRATA

The legends for fìgures 1 and 2 in the article “Ccrcbral hypcrpcrfusion syndromc following aortocarotid bypass surgcp“ (Waikar HD. et al: J Cardiothomc Vast Anesth 7:46 1-465. 1943) should rcad

Fig. 1. Arch aortogram showing total occlusion of the left common carotid artery, both subclavian arteries, and stenosis of the innominate artery, and the proximal right common carotid artery. (Reprinted with permission of Springer-Verlag.)

Fig. 2. Postoperative CT scan shows bihemispheric hematoma more on the right side. (Reprinted with permission of Springer-Verlag.)

Thc correct vcrsions of tables 1 and 7 and thc tigure legend for Fig 4 in thc article “Diltiazcm and regional left ventricular

function during gradcd coronary constriction and propofol anesthcsia in thc dog” (Goldberg AH. ct al. J Cardiothorac VUSC Anrsth 7:705-710. 1993) are rcprinted bclow. On page 705. column 2. lint 2. thc dosage of morphinc sulfatc should read 0.1

mgikg, IM.

Fig. 4. Regression analysis of postsystolic shortening versus LAD coronary blood How (means t SE). The slope of each regression line is significantly different from zero (prediltiazem P = 0.018, postdiltiazem P = 0.012), while also being coincident with the other (P = 0.348). Abbreviations: TS, total muscle shortening; LAD, left anterior descending coronary artery.

Table 1. Global Hemodynamics Dwing Graded Irchsmia and Diltiazrm (means i SD)

Parameter COIltrOl Ischemia

2 TOlal

Occlusiorl

Heart rate (beats/min)

Systolic arterial pressure (mmlig)

Diastolic arterial pressure ImmHg)

LV dP/d& (mmHg/sec)

Systemic vascular resistance (mmHg/L/minl

Stroke volume (mL1

Cardiac output ImLlmin)

LAD coronary blood flow (mL/min/lOO g)

LAD coronary blood flow I% of Control)

LV end-diastolic pressure (mmHg)

Coronary perfusion pressure ImmHgl

103.8 i 24.6$ 120.4 L 17.8t9

128.6 + 14.3$

97.9 + 12.6tl

98.6 + 8.1Z

69.5 + 16.2t§

1696.3 i 457:

1206.3 - 228tS

71 .a -L_ 35.9*

68.4 + 22.25

17.7 I 6.9$ 10.5 + 3.4t4.

2480 + 184$ 1777 + 123tl

120.2 + 42.4$

90.7 + 38.4TS

100 + o* 100 I os

8.3 z 2.4* 4.8 1 Z.OT§

90.4 i 7.56$ 64.8 i 16.2t§

107.8 c 28.3 122.3 L 18.Jt

121.5 t 11.4

92.63 2 10.8t

95.2 + 9.9

63.1 z 14.5t

1618.8 r 396

1205.0 z 319t

76.1 c 34.8

67.8 ? 18.8

15.3 2 6.4

9.6 ? 3.3t

2330 z 165

1808 ? 113t

86.2 z 30.1’

65.6 z 21.2’

76.6 ? 32.4’

76.5 5 14.1*

6.3 1 1.8 4.4 ? 1.6

89.0 = 10.3

58.8 2 14.5t

??P < 0.05 v Control. -

tP < 0.05 prediltiazem Y postdiltiazem SPrediltiazem. SPostdiltiazem.

115.9 + 22.9‘

124.0 % 18.9

116.0 i 9.7’ 93.63 + 11.2t

89.5 z 10.0

66.1 I 15.6t

1432.5 + 279’ 1180.0 + 209t

78.8 i 47.5 73.9 t 24.4

13.5 i 6.1 9.1 z3,3*t

2189 + 157 1807 f 109t

68.3 t 23.0‘ 56.6 L 22.1’

61.0 ? 24.1’ 65.6 z 17.8’

5.8 t 2.0 4.6 I 1.7

83.8 r 10.1

61.6 i 15.4t

117.6 + 22.6’

124.8 z 16.9

114.8 t 7.7’ 89.38 2 13.2t

89.9 + ll.3

62.0 z 13.Jt

1413.8 i 295’

1086.3 i 230t

74.6 + 28.6

74.1 + 22.9

12.7 - 4.1

8.5 2 3.2.t

2073 + 148’

1788 + 104t

50.0 i la.?* 41.8 + 18.8.

47.6 5 27.3* 47.4 L 11.5’

8.5 I 4.4 5.3 I 1.4

81.4 L 12.2 56.7 I 13.2t

125.1 2 22.7’ 128.4 i 16.2’

105.1 c 12.2’ 86.0 2 ll.Ot

79.6 : 13.7’

60.6 z 12.8t

1291 z 278’

1025 L 205t

70.7 z 27.4 75.1 i 20.8

ll.2 L 3.6’ 7.8 L 2.J’t

1897 L 137’ 1533 r gat

0 2 0’ 0 2 0’

0 c 0’ 0 2 0’

9.6 T 4.0 9.0 2 3.2’

70.0 2 13.6’ 51.6 z 12.4.t

258 Journal of Cardiothoraoc and Vascular Anesthesra, Vol 8, NO 2 (April). 1994: pp 258-259

ERRATA 259

Table 2. Regional Muscle Function Dwing Graded Ischemia rnd Dlftiarsm (meanr z SD)

P0hSlOll CrltlCd Ischemta Ischemia TOtal

Territory Parameter COlllV3l Conslrlction 1 2 OCClUSlOn

LAD End-diastolic length (mm) 10.85 + 2.74$ 10.46 z 2.76 10.56 + 2.74 11.41 + 3.27 ll.73 + 3.12.

9.86 ? 2.46tS 9.71 z 2.46 9.93 f 2.59 10.45 + 3.06t 11.15 + 2.93’

LAD Systolic shortening (% EDL) 22.61 + 5.8$ 23.04 z 7.9 15.78 + 5.5’ 7.63 + 3.6’ 4.01 2 2.7’

19.56 + 10.05 18.55 z 9.7 15.24 + 6.9 8.43 f 4.9’ 2.18 +_ 2.0’

LAD Postsystolic shortening 5.29 z 6.33s 4.85 ? 7.25 36.26 i 19.35’ 74.85 ? 20.69’ 100.0 + 0’

(% TS) 11.50 f 12.495 ll.33 z 12.89 31.11 ? 19.31 63.73 ? 32.9’ 100.0 + 0’

LC End-diastolic length 11.28 z 1.79: 10.93 z 1.66’ 10.93 z 1.61’ 11.14 2 1.54 ll.25 + 1.68

(mm) 10.64 + 1.56t§ 10.54 z 1.54t 10.52 1 1.57t 10.63 + 1.73t 10.95 + 1.65’t

LC Svstolic shortening 17.28 -t 3.41: 15.93 I 3.29 16.11 t 6.11 17.99 2 5.69 19.29 + 6.35 (% EDL) 15.54 + 5.235 15.69 z 4.97 14.88 z 4.94 16.64 z 5.97 16.95 + 6.47

LC Postsystolic shortening 9.53 z 10.98* 7.89 z 15.89 7.04 k 17.5 0.66 2 1.87 0.6 + 1.70

1% TS) 6.59 ? 9.215 6.74 -e 9.98 4.91 i 9.54 3.96 5 8.82 4.16 + ll.77

Abbreviations: LAD, left anterior descending; LC, left circumflex; EDL. end-diastolic length; TS, total shortening. ‘P < 0.05 v Control.

tP < 0.05 Prediltiazem v postdiltiazem. SPrediltiazem.

SPostdiltiazem.